Avoidance of sun exposure as a risk factor for major causes of death: a competing risk analysis of the Melanoma in Southern Sweden cohort

Journal of Internal Medicine

Volumn 280, Issue 4, 2016, Pages 375-387

  Lindqvist, P G ^a   Epstein, E ^a   Nielsen, K ^b   Landin Olsson, M ^c   Ingvar, C ^c   Olsson, H ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cigarette smoke; cohort study; CVD; melanoma; mortality; public health

Indexed keywords

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; CANCER MORTALITY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DEATH; FEMALE; FOLLOW UP; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MELANOMA; MIDDLE AGED; NEOPLASM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SUN EXPOSURE;

EID: 84988428079     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12496     Document Type: Article

References (50)

1. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014; 348: g2035.
2. Chowdhury R, Kunutsor S, Vitezova A et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014; 348: g1903.
3. Lindqvist PG, Epstein E, Landin-Olsson M et al. Avoidance of sun exposure is a risk factor for all-cause mortality: results from the Melanoma in Southern Sweden cohort. J Intern Med 2014; 276: 77–86.
4. Reszko A, Aasi SZ, Wilson LD, Leffel DJ. Cancer of the Skin. In: DeVita VT, Lawrence TS, Rosenberg SA, DePinho RA, Weinberg RA, ed. Cancer Principles & Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins, A Wolters Kluwer Business, 2011; 1610–31.
5. Nordcan. Sweden cutaneous malignant melanoma. 2013 [cited 2014 August 25]; Incidence and mortality of malignant melanoma in Sweden 2007-11]. Available from: http://www-dep.iarc.fr/NORDCAN/SW/statsFact.asp?cancer=290&country=752.
6. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Statist Assoc 1999; 94: 496–509.
7. Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J 2009; 9: 265–90.
8. Vimaleswaran KS, Berry DJ, Lu C et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013; 10: e1001383.
9. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690–3.
10. Lyssenko V, Nagorny CL, Erdos MR et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009; 41: 82–8.
11. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 7: 4.
12. Sohmiya M, Kanazawa I, Kato Y. Seasonal changes in body composition and blood HbA1c levels without weight change in male patients with type 2 diabetes treated with insulin. Diabetes Care 2004; 27: 1238–9.
13. Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008; 51: 1391–8.
14. Hypponen E. Vitamin D and increasing incidence of type 1 diabetes-evidence for an association? Diabetes Obes Metab 2010; 12: 737–43.
15. van der Mei IA, Simpson S Jr, Stankovich J, Taylor BV. Individual and joint action of environmental factors and risk of MS. Neurol Clin 2011; 29: 233–55.
16. Smolders J, Thewissen M, Peelen E et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE 2009; 4: e6635.
17. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011; 7: 337–45.
18. Martineau AR, Timms PM, Bothamley GH et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242–50.
19. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91: 1255–60.
20. Camargo CA Jr, Ganmaa D, Frazier AL et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 2012; 130: e561–7.
21. Murdoch DR, Slow S, Chambers ST et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA 2012; 308: 1333–9.
22. Bergman P, Norlin AC, Hansen S et al. Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open 2012; 2: e001663.
23. Tran B, Armstrong BK, Ebeling PR et al. Effect of vitamin D supplementation on antibiotic use: a randomized controlled trial. Am J Clin Nutr 2014; 99: 156–61.
24. Wang WJ, Gray S, Sison C et al. Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea. Therap Adv Gastroenterol 2014; 7: 14–9.
25. Martineau AR, James WY, Hooper RL et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 2015; 3: 120–30.
26. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 2011; 11: 584–96.
27. Juzeniene A, Moan J. Beneficial effects of UV radiation other than via vitamin D production. Dermatoendocrinol 2012; 4: 109–17.
28. Cannell JJ, Grant WB, Holick MF. Vitamin D and inflammation. Dermatoendocrinol 2014; 6: e983401.
29. Scragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol 1981; 10: 337–41.
30. Nayha S. Cold and the risk of cardiovascular diseases. A review. Int J Circumpolar Health 2002; 61: 373–80.
31. Khan FA, Engstrom G, Jerntorp I, Pessah-Rasmussen H, Janzon L. Seasonal patterns of incidence and case fatality of stroke in Malmo, Sweden: the STROMA study. Neuroepidemiology 2005; 24: 26–31.
32. Lindqvist P, Epstein E, Olsson H. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis JTH 2009; 7: 605–10.
33. Epstein D, Kvanta A, Lindqvist PG. Seasonality and incidence of central retinal vein occlusion in Sweden: a 6-year study. Ophthalmic Epidemiol 2015; 22: 94–7.
34. Brondum-Jacobsen P, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. 25-Hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18 791 participants. J Thromb Haemost 2013; 11: 423–31.
35. Brodin E, Lerstad G, Grimnes G et al. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromso Study. Thromb Haemost 2013; 109: 885–90.
36. Folsom AR, Roetker NS, Rosamond WD et al. Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost 2014; 12: 1455–60.
37. Schottker B, Jorde R, Peasey A et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 2014; 348: g3656.
38. Wang L, Song Y, Manson JE et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012; 5: 819–29.
39. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009; 6: 621–30.
40. Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet 1998; 352: 709–10.
41. Oplander C, Volkmar CM, Paunel-Gorgulu A et al. Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ Res 2009; 105: 1031–40.
42. Feelisch M, Kolb-Bachofen V, Liu D et al. Is sunlight good for our heart? Eur Heart J 2010; 31: 1041–5.
43. von Kanel R. Acute mental stress and hemostasis: When physiology becomes vascular harm. Thromb Res 2015; 135(Suppl 1): S52–5.
44. Lindqvist PG, von Kanel R. How to avoid venous thromboembolism in women at increased risk – with special focus on low-risk periods. Thromb Res 2015; 136: 513–18.
45. Fell GL, Robinson KC, Mao J, Woolf CJ, Fisher DE. Skin beta-endorphin mediates addiction to UV light. Cell 2014; 157: 1527–34.
46. Lindelöf B, Krynitz B, Ayoubi S, Martschin C, Wiegleb-Edström D, Wiklund K. Previous extensive sun exposure and subsequent vitamin D production in patients with basal cell carcinoma of the skin, has no protective effect on internal cancers. Eur J Cancer 2012; 48: 1154–8.
47. Newton-Bishop JA, Beswick S, Randerson-Moor J et al. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol 2009; 27: 5439–44.
48. Jensen AO, Lamberg AL, Jacobsen JB, Braae Olesen A, Sorensen HT. Non-melanoma skin cancer and ten-year all-cause mortality: a population-based cohort study. Acta Derm Venereol 2010; 90: 362–7.
49. Yang L, Lof M, Veierod MB, Sandin S, Adami HO, Weiderpass E. Ultraviolet exposure and mortality among women in Sweden. Cancer Epidemiol Biomarkers Prev 2011; 20: 683–90.
50. Lindqvist PG. On elucidating a possible link between vitamin D and venous thromboembolism–finding a piece of the puzzle. Thromb Haemost 2013; 109: 787–8.